Sponsors

Amgen

Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.

Amgen focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.

AstraZeneca

AstraZeneca is a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection and neuroscience diseases. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.

Boehringer Ingelheim

Improving the health and quality of life of patients is the goal of the research-driven pharmaceutical company Boehringer Ingelheim. The focus in doing so is on diseases for which no satisfactory treatment option exists to date. The company therefore concentrates on developing innovative therapies that can extend patients’ lives.

DKSH

Healthcare Growing healthcare businesses across Asia DKSH is a leading provider of Market Expansion Services for pharmaceutical, over-the-counter (OTC), consumer health and medical device companies seeking to grow their business in Asia. We provide a wide range of integrated and customized solutions, including registration, market entry studies, marketing and sales, redressing, physical distribution, as well as invoicing and cash collection.

Headquartered and publicly listed in Switzerland, we have a strong local healthcare presence in 13 Asian markets.

In our more than 150 years in Asia, we have built a capillary distribution network of unique scope and depth that includes 130,000 professional healthcare outlets such as hospitals, clinics, doctors, pharmacies, drugstores, dentists and optical outlets. We can also tap into our network of retail outlets if required and develop new channels, such as e-commerce. With the deep market knowledge provided by our 8,220 healthcare specialists, as well as our commitment to international quality standards and corporate compliance, we set the benchmark in Asia.

Hyphens Pharma

Hyphens Pharma focuses on the sales and marketing of specialty pharmaceutical products in selected ASEAN countries through exclusive distributorship or licensing and supply agreements with brand principals mainly from Europe and the United States. The major products in our product portfolio include Vivomixx™, Fenosup® , D-Cure® and Piascledine®. In addition, Hyphens Pharma develops, markets and sells our proprietary range of dermatological products marketed under our Ceradan® and TDF® brands as well as health supplement products marketed under our Ocean Health® brand.

Novo Nordisk

Novo Nordisk is a global healthcare company with more than 95 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat other serious chronic diseases: obesity, haemophilia, and growth disorders. Headquartered in Denmark, Novo Nordisk employs approximately 42,700 people in 80 countries and markets its products in more than 170 countries.

Sanofi

Servier

SERVIER Laboratories, founded in 1954, is an international pharmaceutical company governed by a non-profit foundation, with its headquarters in France. We are a research-based organization, specialized in cardiology, diabetes, neuroscience, venous disease and oncology. We aim to participate in the discovery of innovative drugs through research; to offer therapeutic solutions to meet the needs of the physicians and their patients; to be attuned to the needs of the staff and to contribute to the achievement of everyone’s aspiration through the company. Currently, we are present in 149 countries with more than 22,000 employees, including close to 3000 in R&D.